Integris Healthcare, a global diversified medical technology (MedTech) company, announced the appointment of Probir Das as Chief Executive Officer. He will join effective November 2024 and will be based in New Delhi, India. With over three decades of global MedTech experience, Probir will lead the next phase of growth and innovation for the Company. Probir joins Integris from Terumo Asia Pacific, where he served as Chairman & Managing Director since 2019.
Avnish Mehra, Vice Chairman – Everstone Capital commented, “Probir’s exceptional track record of scaling businesses at Terumo both in India and in Southeast Asia, combined with his years of experience in India at Becton Dickenson and at Boston Scientific make him the ideal leader to take Integris to new heights.”
Gurmit Chugh, Co-Founder the cardiovascular business within Integris (along with Punita Sharma) said, “I have seen Probir scaling many businesses in the last 25 years with his deep understanding of MedTech markets. He is an inspiring leader who creates a culture of collaboration and accountability empowering teams to exceed their goals. He is highly regarded for his adaptability and commitment to sustainable growth.”
Probir Das commented, “Throughout my career, I have focused on driving innovation, establishing new therapies, and fostering rapid growth in the MedTech sector. Together with Integris’ talented team, I look forward to expanding our market presence, delivering cutting-edge medical technologies to patients worldwide, and ultimately transforming healthcare delivery on a global scale.”
About Integris:
Integris is a diversified MedTech platform with four key business segments: Cardiovascular Devices, Clinical Diagnostics, Scientific Lab Solutions, and Vascular Access Therapies. The platform provides a strong product development and manufacturing core, coupled with unparalleled access to customers across the world. The company has R&D expertise and manufacturing facilities set out of India, Germany and Netherlands with strong global compliance. Integris also has strong distribution and commercialization platforms in some key strategic markets for distributing unique and innovative technologies from other MedTech players. Integris is backed by Everstone Capital and promoters Gurmit Chugh & Punita Arora.
About Everstone Capital:
Everstone Capital is the Private Equity business of the Everstone Group, a global firm with assets under management of over USD 8 Bn committed to driving economic growth and creating sustainable value in India and Southeast Asia, with a mission to build great businesses with extraordinary people. Everstone Capital is focused on mid-market, control growth and cross-border opportunities spanning Technology, Healthcare, Financial Services, and Industrials.